Eledon Pharmaceuticals
ELDN
ELDN
15 hedge funds and large institutions have $3.45M invested in Eledon Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$240K | |
| 2 | +$16.7K | |
| 3 | +$7.99K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.68K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$201 |
Top Sellers
| 1 | -$273K | |
| 2 | -$166K | |
| 3 | -$25.2K | |
| 4 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
-$23K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$23K |